Evidence map›Paper›PMID 30410210›Full record

ReviewAustralian prescriber2018

Treatment of irritable bowel syndrome.

Chamara Basnayake

Open access · diamondAbstract readReview
In one paragraph

Review in Australian prescriber, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Linking Life Aspirations to Functional Medical Conditions: A Goal Contents Theory Perspective.International journal of environmental research and public health · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Irritable bowel syndrome diagnosis.Australian prescriber · 2019
    Article
  10. Article
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Chamara BasnayakeSt Vincent's Hospital, Melbourne.
University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IRRITABLE BOWEL SYNDROME IS A CHRONIC FUNCTIONAL GASTROINTESTINAL DISORDER THAT PRESENTS WITH ABDOMINAL PAIN RELATED TO DEFECATION ACCOMPANIED BY A CHANGE IN STOOL FREQUENCY OR FORM DESPITE ITS IMPACT ON A PATIENT’S QUALITY OF LIFE IT HAS NO EFFECT ON MORTALITY: A POSITIVE CLINICAL DIAGNOSIS SHOULD BE MADE IF THE CHARACTERISTIC SYMPTOMS ARE PRESENT AND RED FLAGS ARE ABSENT RED FLAGS SHOULD PROMPT SPECIALIST REFERRAL: CONSULTATIONS SHOULD BE PROVIDED IN AN EMPATHETIC MANNER ADDRESSING THE CONCERNS OF THE PATIENT WHILE PROVIDING REASSURANCE: MANIPULATING DIET WITH THE ASSISTANCE OF A DIETITIAN IS AN APPROPRIATE INITIAL TREATMENT FOR IRRITABLE BOWEL SYNDROME A LOW-FODMAP DIET IS AN EFFECTIVE THERAPY:

Indexed as

constipationdiarrhoeairritable bowel syndromelow-FODMAP dietpsychological therapy

Identifiers

PMID30410210
PMCPMC6202292
OpenAlexW2893531070

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.